Scholarly Index
Prithviraj Bose
The University of Texas MD Anderson Cancer Center; 9,489 total citations; 600 total publications; best world rank #16
The University of Texas MD Anderson Cancer Center
9,489Total citations
600Total publications
49H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 212 | US 102 | 98.26 |
| Acute Myeloid Leukemia Research | Lifetime | 601 | US 276 | 98.42 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 407 | US 201 | 98.09 |
| Eosinophilic Disorders and Syndromes | Lifetime | 355 | US 169 | 97.37 |
| Kruppel-like factors research | Lifetime | 190 | US 77 | 95.94 |
| Multiple Myeloma Research and Treatments | Lifetime | 876 | US 393 | 95.93 |
| Histone Deacetylase Inhibitors Research | Lifetime | 653 | US 310 | 94.60 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 28 | US 19 | 99.28 |
| Acute Myeloid Leukemia Research | 2021-2025 | 74 | US 47 | 99.23 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 22 | US 15 | 98.96 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 58 | US 38 | 98.91 |
| Kruppel-like factors research | 2021-2025 | 16 | US 9 | 97.70 |
| Mast cells and histamine | 2021-2025 | 34 | US 11 | 96.39 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 385 | US 173 | 96.03 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 586 | US 272 | 92.37 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 565 | US 266 | 89.65 |